Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Electronic reporting of diagnostic laboratory test results from all health care sectors is a cornerstone of national preparedness and control of COVID-19 in Denmark

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. APMIS pandemic editorial

    Research output: Contribution to journalEditorialResearchpeer-review

  2. Pandemics: past, present, future: That is like choosing between cholera and plague

    Research output: Contribution to journalReviewResearchpeer-review

  3. Status: nosocomial transmission and prevention of SARS-CoV-2 in a Danish context

    Research output: Contribution to journalReviewResearchpeer-review

  4. Beta-hemolytic streptococci A, C and G are susceptible to cloxacillin

    Research output: Contribution to journalLetterResearchpeer-review

  5. The discovery of bacterial biofilm in patients with muscle invasive bladder cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  • K Schønning
  • Rbc Dessau
  • T G Jensen
  • N M Thorsen
  • C Wiuff
  • L Nielsen
  • S Gubbels
  • M Denwood
  • U H Thygesen
  • L E Christiansen
  • C H Møller
  • J K Møller
  • S Ellermann-Eriksen
  • C Østergaard
  • J Lam
  • N Abushalleeh
  • M Meaidi
  • S S Olsen
  • K Mølbak
  • M Voldstedlund
View graph of relations

The COVID-19 pandemic has led to an unprecedented demand for real-time surveillance data in order to inform critical decision makers regarding the management of the pandemic. The aim of this review was to describe how the Danish national microbiology database, MiBa, served as a cornerstone for providing data to the real-time surveillance system by linkage to other nationwide health registries. The surveillance system was established on an existing IT health infrastructure and a close network between clinical microbiologists, information technology experts, and public health officials. In 2020, testing capacity for SARS-CoV-2 was ramped up from none to over 10,000 weekly PCR tests per 100,000 population. The crude incidence data mirrored this increase in testing. Real-time access to denominator data and patient registries enabled adjustments for fluctuations testing activity, providing robust data on crude SARS-CoV-2 incidence during the changing diagnostic and management strategies. The use of the same data for different purposes, for example, final laboratory reports, information to the public, contact tracing, public health, and science, has been a critical asset for the pandemic response. It has also raised issues concerning data protection and critical capacity of the underlying technical systems and key resources. However, even with these limitations, the setup has enabled decision makers to adopt timely interventions. The experiences from COVID-19 may motivate a transformation from traditional indicator-based public health surveillance to an all-encompassing information system based on access to a comprehensive set of data sources, including diagnostic and reference microbiology.

Original languageEnglish
JournalAPMIS - Journal of Pathology, Microbiology and Immunology
Volume129
Issue number7
Pages (from-to)438-451
Number of pages14
ISSN0903-4641
DOIs
Publication statusPublished - Jul 2021

Bibliographical note

Publisher Copyright:
© 2021 APMIS. Published by John Wiley & Sons Ltd

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

    Research areas

  • COVID-19, electronic reporting, microbiological test results, national surveillance

ID: 65429758